The Chairman of Next Green Wave Holdings is Exercising Options

By Carrie Williams

Today it was reported that the Chairman of Next Green Wave Holdings (NXGWFResearch Report), Robert Michael Dzisiak, exercised options to sell 100,000 NXGWF shares for a total transaction value of $40K.

Over the last month, Robert Michael Dzisiak has reported another 5 Sell trades on NXGWF for a total of $106.5K. In addition to Robert Michael Dzisiak, 2 other NXGWF executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Next Green Wave Holdings’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $3.17 million and quarterly net profit of $2.89 million. In comparison, last year the company earned revenue of $58.02K and had a GAAP net loss of $2.27 million. Currently, Next Green Wave Holdings has an average volume of 196.15K.

In the last 30 days, insiders have sold $166.1K worth of NXGWF shares and purchased $83.8K worth of NXGWF shares. The insider sentiment on Next Green Wave Holdings has been negative according to 20 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Next Green Wave Holdings Inc is a vertically integrated seed-to-consumer premium medicinal and recreational cannabis company operating in California. The company’s first indoor facility with approximately 35,000 square feet is now entering production with future plans to expand the 15 acres of cannabis zoned land it is situated on. It has acquired a seed library of over 120 strains which include several award-winning genetics and cultivars. The company’s investment in Omega Medical Growth will provide access to distribution through the licensing of brands through Colombia.